GlassScriptPhysician profile
John J Kritsas
NPI 1134129018
$7,653.27
in general payments reported to CMS, 2019-2025
56 companies · $1,287 in 2025
The $1,287 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $300 · 2021: $1,297 · 2022: $1,251 · 2023: $1,198 · 2024: $1,162 · 2025: $1,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,286 · Education: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,286.13 |
| Education | $361.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,722.24 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $644.05 | 2019-2025 | Provenge |
| Abbvie INC. | $629.76 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $481.48 | 2019-2025 | |
| Janssen Biotech, INC. | $386.71 | 2019-2025 | Erleada |
| Pfizer INC. | $364.60 | 2019-2025 | |
| Blue Earth Diagnostics | $263.31 | 2019-2025 | Posluma |
| Merck Sharp & Dohme LLC | $250.27 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $214.24 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $164.54 | 2021-2024 | Prolaris |
| Antares Pharma, INC. | $135.50 | 2019-2022 | |
| Coloplast Corp | $134.63 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $130.74 | 2019-2023 | Xiaflex, Edex, Aveed |
| Myovant Sciences INC. | $122.53 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $120.54 | 2021-2025 | Pylarify |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kritsas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.